| 10:30 - 11:45 | EP Masterclass 1 | |
| 10:30 - 11:45 | Oral Abstracts | |
| 11:30 - 19:00 | EP Traces Course | |
| 12:15 - 13:30 | Oral Abstracts | |
| 12:15 - 13:30 | Masterclass Devices 1 - New Technologies; and the advantages it creates | |
| 14:45 - 16:15 | A-A Symposia - Sharing knowledge to optimise VT ablation outcomes in the UK | |
| 14:45 - 16:15 | Nurses 1 | |
| 14:45 - 16:15 | AF Association Symposia - Restoring the Rhythm | |
| 16:45 - 18:15 | A-A Symposia - Implantable cardiac devices | |
| 16:45 - 18:15 | AF Association Symposia - Is the future of DOAC's bright? | |
| 16:45 - 18:15 | Cases and Traces |
| Chair: Dr Anoop Shetty | London, UK | |||
|---|---|---|---|---|
| 12:15 | Inequalities created by wearables | |||
| 12:30 | Improving communications; remote analysis messaging tools | Ms Katie Thommason | London, UK | |
| 12:45 | Leadless Pacemakers | Dr Anoop Shetty | London, UK | |
| 13:00 | ICD Deactivation; recognising when to deactivate | |||
| 13:15 | Q and A | |||
| 13:30 | Close |
| Chair: | ||||
|---|---|---|---|---|
| 14:45 | How to find and eliminate the culprit VT Conduction Channels | |||
| 15:05 | VT Voltage mapping - the Liverpool approach | Dr Vishal Luther | Liverpool, UK | |
| 15:25 | Let's simplify VT ablation - targeting the functional substrate | |||
| 15:45 | Novel Tools for Optimising VT Ablation: Going beyond Electroanatomical Mapping | Dr Shui Hao Chin | Leicester, UK | |
| 16:05 | Q and A | |||
| 16:15 | Close |
| Chair: Dr Angela Hall | Jersey, UK | |||
|---|---|---|---|---|
| 14:45 | Thyroid dysfunction and arrhythmias | |||
| 15:00 | How many ectopic's count? | Dr Chris Brown | Jersey, UK | |
| 15:15 | Menopause and AF | |||
| 15:30 | Management of heart failure with rEF and pEF | |||
| 15:45 | AF ablation and raised BMI, research outcomes | |||
| 16:00 | Q and A | |||
| 16:15 | Close |
| Chair: Prof Natasja de Groot | Rotterdam, NL | |||
|---|---|---|---|---|
| 14:45 | Beyond PVI in Ablating Persistent AF - What is the evidence? | Dr Vias Markides | London, UK | |
| 15:00 | Is PVI relevant in congenital heart disease? | Prof Natasja de Groot | Rotterdam, NL | |
| 15:15 | Restoring the rhythm in HFpEF - Is there any evidence? | Dr Rosita Zakeri | London, UK | |
| 15:30 | AF in HFrEF - Is restoration to sinus rhythm for everyone? | Prof Mark Petrie | Glasgow, UK | |
| 15:45 | Should we ablate AF in Hypertrophic Cardiomyopathy? | |||
| 16:00 | PFA in AF ablation - What are the Pit Falls? | |||
| 16:15 | Close |
| Chair: Dr Jenny Chuen | Nottingham, UK | |||
|---|---|---|---|---|
| 16:45 | Can we predict who will require a pacemaker post TAVI? | |||
| 17:00 | Risks and benefits of ICD's in patients with end stage renal failure | |||
| 17:15 | Extravascular ICD's using a substernal approach: safety, feasibility and implantation technique | |||
| 17:30 | My approach to conduction system pacing implantation | Dr Badrinathan Chandrasekaran | Swindon, UK | |
| 17:45 | Update on clinical trials in conduction system pacing | |||
| 18:00 | Q and A | |||
| 18:15 | Close |
| 16:45 | Does the diabetic patient benefit more from DOACs that VKAs | |||
| 17:05 | What is the evidence that DOACs can be used in severe renal failure | |||
| 17:25 | Why should patients take DOACs if a simple Left atrial appendage occluder can prevent strokes just as well? | |||
| 17:45 | Will Factor XI inhibitors take over from DOACs? | |||
| 18:05 | Panel Discussion & Q & A |